L. (2011). its canonical ligand vitamin D and switched its heterodimer binding\partner from RXR to p53. The VDR/p53 complex localized mostly in the cytosol, improved neuronal autophagy and apoptosis. Chemically inhibiting p53?switched VDR back to RXR, reversing amyloidosis and cognitive impairment in Rabbit Polyclonal to EXO1 AD mice. These results suggest a non\genomic rewiring of VDR to p53 is definitely important for the progression of AD, and thus VDR/p53 pathway might be targeted to treat people with AD. test. (b) Immunohistochemistry analysis of VDR in sections of CA (Cornu Ammonis) Apocynin (Acetovanillone) areas in AD and non\AD controls. Scale bars, 20?m. (c) Western blot analysis of VDR levels in hippocampus of APP/PS1 and WT mice at 13?weeks of age. (d) Representative?images of?immunohistochemistry analysis for MAP2 (neuronal marker) and VDR in sections of CA regions of hippocampus in APP/PS1?mice. Right panel shows the quantification of the nuclear and cytoplasmic protein levels of VDR in AD brains (test. (b) A42 decreases VDRCRXR Apocynin (Acetovanillone) interaction inside a dose\dependent manner. SH\SY5Y cells were treated with 100?nM calcitriol and A42 (2, 4 or 6?M) for 6?h before harvesting for mammalian two\cross luciferase assays. (c) Decreased Cyp24a1 (a known VDR target gene) gene manifestation in neuronal cells exposed to A42. SH\SY5Y cells were treated with 100?nM calcitriol and/or 4?M A42 for 6?h prior to qPCR analysis of the Cyp24a1 expressions. (d) Cyp24a1 promoter reporter assay in neuronal cells exposed to A42. SH\SY5Y cells were treated with 100?nM calcitriol or A42 (2, 4 or 6?M) for 6?h before harvesting for luciferase assays. (e) Western blot analysis of co\immunoprecipitated VDR and p53 in neuronal cells. (f) Representative immunofluorescent micrographs showing p53 and VDR colocalized in hippocampal cells of human AD brains. Hippocampal CA regions of AD individuals were labelled with antibodies against VDR and p53. Scale bars, 20?m. (g) Duolink? proximity ligation assay for protein connection between VDR and p53 in human being hippocampal cells. Scale bars, 20?m. AD, Alzheimers disease; qPCR, quantitative actual\time reverse transcription\polymerase chain reaction; RXR, retinoid X receptor; SEM, standard error of the mean; VDR, vitamin D receptor Vitamin D receptor usually forms heterodimers with additional transcription factors but we found no connection between VDR and RXR, so we started to wonder whether VDR switched its interacting collaboration with RXR to another transcription element. P53?has been shown to interact with and modulate VDR activity in tumor cell apoptosis (Stambolsky et al., 2010), and most importantly, p53 protein has been found out to be upregulated in AD brains (de la Monte et al., 1997). Consequently, we wanted to test whether VDR binding with RXR was rewired somehow to bind to p53. To determine whether the formation of VDR/p53 complex was induced from the direct cellular effect of A42, we performed co\immunoprecipitation assays finding that A induced VDR/p53 connection in SH\SY5Y cells and that this connection was further enhanced with the help of vitamin D3 (Number ?(Figure3e).3e). Similarly, double\labeling immunocytochemistry showed that both VDR and p53 were colocalized in the cytoplasm (Number ?(Number3f).3f). We performed a proximity ligation assay (PLA) to study the association between VDR and p53 Apocynin (Acetovanillone) in the postmortem brains of AD patients. As we had found in mice, VDR/p53 complex was abundant in the plaque areas in the brain sections (Number ?(Figure3g).3g). Moreover, Western blot analysis also suggested that both VDR and p53 protein levels were improved while the levels of MDM2, an enzyme focusing on p53 for degradation by ubiquitination, were concomitantly decreased in human being brains (Number ?(Figure4).4). Consistent with the observations in AD brain cells, the Western blot results also showed that both the VDR and p53 proteins were also mainly localized within the cytosolic compartment in Apocynin (Acetovanillone) SH\SY5Y cells exposed to.
L